TIDMHIK

RNS Number : 2641U

Hikma Pharmaceuticals Plc

21 November 2019

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Mohammed 'Ali' Al-Husry 
 2    Reason for the notification 
 a)   Position/status           Non-Executive Director 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             ID Code: GB00B0LCW083 
       instrument, type 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Mr. Al-Husry has a beneficial interest in DKYB 
       transaction               Limited, which holds shares in Hikma. DKYB Limited 
                                 previously had 1,109,748 Hikma shares pledged 
                                 to Citibank Switzerland. On 19 November 2019 
                                 the pledge arrangement was changed so that 989,748 
                                 shares were pledged to Citibank Jersey and 120,000 
                                 shares were pledged to Citibank Switzerland. 
                                 Both Citibank Switzerland and Citibank Jersey 
                                 are ultimately wholly owned by Citigroup Inc. 
 c)   Price(s) and              Price(s): GBP0.00p 
       volume(s)                 Volume(s): 0 
 d)   Aggregated information    Aggregated volume: 0 
                                 Price: GBP0.00p 
 e)   Date of the transaction   19 November 2019 
 f)   Place of the              London 
       transaction

Peter Speirs, Company Secretary, Responsible for releasing this announcement

21 November 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBSBDBLSDBGCB

(END) Dow Jones Newswires

November 21, 2019 09:47 ET (14:47 GMT)

Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Mar 2024 a Apr 2024 Clicca qui per i Grafici di Hikma Pharmaceuticals
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Apr 2023 a Apr 2024 Clicca qui per i Grafici di Hikma Pharmaceuticals